SEARCH

SEARCH BY CITATION

References

  • 1
    Jansen A, Homodelarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta- cell destruction in NOD mice. Diabetes 1994; 43:66775.
  • 2
    Hutchings PR, Simpson E, O'Reilly LA, Lund T, Waldmann H, Cooke A. The involvement of Ly2+ T cells in beta cell destruction. J Autoimmun 1990; 1:1019.
  • 3
    Jun HS, Yoon CS, Zbytnuik L, VanRooijen N, Yoon JW. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 1999; 189:34758.
  • 4
    Jun HS, Santamaria P, Lim HW, Zhang ML, Yoon JW. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8 (+) T-cells in T-cell receptor transgenic NOD mice. Diabetes 1999; 48:3442.
  • 5
    Hattori M, Buse JB, Jackson RA, et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986; 231:7335.
  • 6
    Lund T, Shaikh S, Kendall E, et al. RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains. Diabetologia 1993; 36:72733.
  • 7
    Ikegami H, Makino S, Yamato E, et al. Identification of a new susceptibility locus for insulin-dependent diabetes-mellitus by ancestral haplotype congenic mappingI. J Clin Invest 1995; 96:193642.
  • 8
    Hattori M, Yamato E, Itoh N, et al. Cutting edge: Homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. J Immunol 1999; 163:17214.
  • 9
    Wicker LS. Major histocompatibility complex-linked control of autoimmunity. J Exp Med 1997; 186:9735.
  • 10
    Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 1994; 43:61321.
  • 11
    Coleman DL, Kuzava JE, Leiter EH. Effect of diet on incidence of diabetes in nonobese diabetic mice. Diabetes 1990; 39:4326.
  • 12
    Kanagawa O, Martin SM, Vaupel BA, CarrascoMarin E, Unanue ER. Autoreactivity of T cells from nonobese diabetic mice: an I-A (g7)-dependent reaction. Proc Natl Acad Sci USA 1998; 95:17214.
  • 13
    DeLuca D, Bluestone JA, Shultz LD, Sharrow SO, Tatsumi Y. Programmed differentiation of murine thymocytes during fetal thymus organ culture. J Immunol Methods 1995; 178:329.
  • 14
    Ridgway WM, Ito H, Fasso M, Yu C, Fathman CG. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J Exp Med 1998; 188:226775.
  • 15
    Acha-Orbea H & McDevitt HO. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci USA 1987; 84:24359.
  • 16
    Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:24552.
  • 17
    Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone-marrow cultures supplemented with granulocyte macrophage colony-stimulating factor. J Exp Med 1992; 176:1693702.
  • 18
    Langmuir PB, Bridgett MM, Bothwell ALM, Crispe IN. Bone-marrow abnormalities in the nonobese diabetic mouse. Int Immunol 1993; 5:16977.
  • 19
    Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141:240712.
  • 20
    Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5:124955.
  • 21
    Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223:7792.
  • 22
    Lee M, Kim AY, Kang Y. Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice. J Korean Med Sci 2000; 15:21723.
  • 23
    Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993; 150:253443.
  • 24
    Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD Lt mice – Defective regulation of cytokine receptors and Protein-Kinase-C. Proc Acad Natl Sci USA 1993; 90:96259.
  • 25
    Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha OH. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 1990; 87:96872.
  • 26
    Morel PA, Vasquez AC, Feili-Hariri M. Immunobiology of DC in NOD mice. J Leukoc Biol 1999; 66:27680.
  • 27
    Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999; 48:23008.
  • 28
    Clare-Salzler MJ, Brooks J, Chai A, Vanherle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992; 90:7418.
  • 29
    Shinomiya M, Fazle Akbar SM, Shinomiya H, Onji M. Transfer of dendritic cells (DC) ex vivo stimulated with interferon- gamma (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1999; 117:3843.
  • 30
    Radosevic K, Casteels KM, Mathieu C, Van Ewijk W, Drexhage HA, Leenen PJ. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells? J Autoimmun 1999; 13:37382.